<DOC>
	<DOCNO>NCT02381587</DOCNO>
	<brief_summary>sjogren syndrome autoimmune disease mainly affect Salivary gland Lacrimal gland In addition effect disease characterize overall systemic Muskals injury , pulmonary disease , peripheral neuropathy vasculitis . In addition recent study show patient increase risk disease 2 cardiac event stroke event Hydroxychloroquine RHEUMATIC DISEASE PROCESS SUPPRESSANTS-ANTIMALARIALS use treat anti-inflammatory rheumatic disease many first-line treatment sjogren syndrome . A recent study treatment Hydroxychloroquine effect lipid profile sjogren syndrome patient show reduction total cholesterol level increase HDL . Further study impact make Hydroxychloroquine systemic lupus patient erythematosus ( SLE ) show Atherosclerosis morbidity mortality reduction cardiovascular . Studies patient rheumatoid arthritis ( RA ) demonstrate reduce risk develop diabetes improve lipid profile Research Goals valuate The effect HCQ treatment cardiovascular patient primary sjogren syndrome</brief_summary>
	<brief_title>Effect HCG Treatment Cardiovascular Disease Morbidity Factor Sjogren Syndrome Patients</brief_title>
	<detailed_description>Research Goals Valuate The effect HCQ treatment cardiovascular patient primary sjogren syndrome Research Methods The study include patient diagnosed sjogren syndrome treat Meir Medical center year 2003-2014 During study collect information confound factor , Risk factor include cardiovascular acceptable diabetes , dyslipidemia , high blood pressure like , central nervous system involvement steroid use Study outcome one follow : 1 . Thrombosis peripheral vein 2 . Arterial cardiovascular event 3 . Cardiac event ( myocardial infarction 4 . Stroke ( stroke TIA ) 4 . Venous thrombosis event 5 . Pulmonary embolism In study 500 patient Inclusion criterion : 1 . 18 year old 2 . Both sexes 3 . Patients diagnosis sjogren treat Meir Medical center year 2003-2014 And treated Hydroxychloroquine least month . Exclusion criterion : 1 . Minors special population 2 . Patients treat Hydroxychloroquine less month . 3 . Patient participate clinical trial treat investigational product</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<criteria>1 . 18 year old 2 . Both sexes 3 . Patients diagnosis sjogren treat Meir Medical center year 20032014 And treat Hydroxychloroquine least month . 1 . Minors special population 2 . Patients treat Hydroxychloroquine less month . 3 . Patient participate clinical trial treat investigational product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>